April 16, 2019 10:23 AM EDT
China

Chi­nese phar­ma­ceu­ti­cal man­u­fac­tur­er in spot­light af­ter weld­ing ac­ci­dent kills 10

Amber Tong

An ac­tive phar­ma­ceu­ti­cal in­gre­di­ent man­u­fac­tur­er in Chi­na has come un­der scruti­ny for the lat­est dead­ly in­dus­tri­al ac­ci­dent af­ter an ex­plo­sive ac­ci­dent at its plant killed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Ax­some moves to­ward NDA fil­ing for nar­colep­sy drug fol­low­ing pos­i­tive Phase 3 da­ta

Soleno’s rare pe­di­atric dis­ease drug faces PDU­FA de­lay by three months

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

A service from the Financial Times